维普期刊资源整合服务平台（V6.5）

64篇 您的检索式：作者名="ZEIMET"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Circulating immu- nostimulatory protein 90K andsoluble inter leukin-2 receptor in human ovarian cancer显示文摘	Zeimet AG Natoli C Herold M	1996	Int J Cancer1996，68，1：	1
2	Prognostic of CD44 splice variant expression in ovarian cancer显示文摘	Uhl Steidl M Miiller Holzner E Zeimet AG	1995	Oncology1995，52，5：	1
3	Ovarian can-cer stem cells显示文摘	Zeimet AG Reimer D Sopper S		0，，06：	1
4	Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125显示文摘	Marth C Offner FA	1996	Gynecol Oncol1996，62，3：	1
5	Human peritoneal mesothelial cells ave more potent than ovarian cancer cells in producing tumor marker CA125 显示文摘	Zeimet AG Marth C Offner FA	1996	Gynecol Oncol1996，62，3：	1
6	Peritoneal mesothelial cells as a significant source of ascitic immunostimulatory protein 90K 显示文摘	Zeimet AG Stadlmann S Natoli C	2000	Anticancer Res2000，20，6：	1
7	New insights into p53 regulation and gene therapy for cancer显示文摘	Zeimet AG Riha K Berger J	2000	Biochem Pharmacol2000，60，8：	1
8	Tumor marker CA-125 in tissues of the female reproductive tract and in serum during the normal menstrual cycle显示文摘	Zeimet AG Mtiller-Holzner EE Marth CC	1993	Fertil Steril1993，59，5：	1
9	Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125显示文摘	Zeimet AG Marth C Offner FA	1996	Gynecol Oncol1996，62，：	1
10	Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125 显示文摘	Zeimet A G Marth C Offner F A	1996	Gynecol Oncol1996，62，3：	1
11	Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA125 显示文摘	Zeimet AG Marth C Offner FA	1996	Gynecol Oncol1996，62，：	1
12	Why did p53 gene therapy fail in ovarian cancer?显示文摘	Marth C	2003	Lancet Oncol2003，4，：	1
13	Prognositic value of CD44 splice variant expression in ovarian cancer显示文摘	Uhl-steidl M Muller-Holzner E Zeimet AG	1995	Oncology1995，52，5：	1
14	Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125显示文摘	Zeimet AG Marth C Offner FA	1996	Gynecol Oncol1996，62，3：	1
15	The side population of o- varian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics 显示文摘	Boesch M Zeimet A G Reimer D	2014	Oncotarget2014，5，16：	1
16	Photodynamic therapy for recurrent gynecologic malignancy: a report on 4 cases显示文摘	Elisabeth Krimbacher A. G. Zeimet C. Marth H. Kostron	1999	Archives of Gynecology and Obstetrics (-)1999，，3：	1
17	Modulation of CA-125 release by inflammatory cytokines in human peritoneal mesothelial and ovarian cancer cells显示文摘	Zeimet AG Offner FA Marth C	1997	Anticancer Res1997，17，4：	1
18	Ascitic intrleukin- 12 is an independent prognostic factoer in ovarian cancer显示文摘	Zeimet AG widschwendTer M Knabbe C	1998	Clin 0ncoi1998，16，5：	1
19	Regulation of CA125 expression in cultured human carcinoma cells显示文摘	Marth C Zeimet AG Widschwendter M	1998	Int J Biol Markers1998，13，4：	1
20	Ascitic Interleukin-12 is an independent prognostic factor in ovarian cancer 显示文摘	Zeimet AG Widschwendter M Knabbe C	1998	J Clin Oncol1998，16，5：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示